Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

iSpecimen (ISPC) Equity Average (2021 - 2025)

Historic Equity Average for iSpecimen (ISPC) over the last 5 years, with Q3 2025 value amounting to $1.8 million.

  • iSpecimen's Equity Average fell 6580.22% to $1.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.8 million, marking a year-over-year decrease of 6580.22%. This contributed to the annual value of $6.5 million for FY2024, which is 5656.58% down from last year.
  • As of Q3 2025, iSpecimen's Equity Average stood at $1.8 million, which was down 6580.22% from $1.1 million recorded in Q2 2025.
  • Over the past 5 years, iSpecimen's Equity Average peaked at $28.7 million during Q1 2022, and registered a low of $1.1 million during Q2 2025.
  • In the last 5 years, iSpecimen's Equity Average had a median value of $11.4 million in 2021 and averaged $13.1 million.
  • As far as peak fluctuations go, iSpecimen's Equity Average soared by 10957.85% in 2022, and later crashed by 8224.78% in 2025.
  • Over the past 5 years, iSpecimen's Equity Average (Quarter) stood at $20.9 million in 2021, then grew by 2.03% to $21.4 million in 2022, then tumbled by 47.47% to $11.2 million in 2023, then tumbled by 64.25% to $4.0 million in 2024, then crashed by 53.96% to $1.8 million in 2025.
  • Its last three reported values are $1.8 million in Q3 2025, $1.1 million for Q2 2025, and $2.5 million during Q1 2025.